Ad is loading...
CBLRX
Price
$54.29
Change
-$0.51 (-0.93%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

CBLRX vs RLEFX

Header iconCBLRX vs RLEFX Comparison
Open Charts CBLRX vs RLEFXBanner chart's image
Columbia Balanced R
Price$54.29
Change-$0.51 (-0.93%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
CBLRX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CBLRX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBLRX is a StrongSell and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. CBLRX (9.72B). RLEFX pays higher dividends than CBLRX: RLEFX (2.42) vs CBLRX (1.47). CBLRX was incepted earlier than RLEFX: CBLRX (14 years) vs RLEFX (9 years). CBLRX (171.00) and RLEFX (171.00) have comparable annual turnover. CBLRX has a lower initial minimum investment than RLEFX: CBLRX (0) vs RLEFX (250). RLEFX (21.09) and CBLRX (20.31) have marching annual gain over last year. RLEFX return over 5 years is better than : 35.95 vs. CBLRX (29.23).
CBLRXRLEFXCBLRX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence14 years9 years-
Gain YTD13.67314.21196%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets9.72B236B4%
Annual Yield % from dividends1.472.4261%
Returns for 1 year20.3121.0996%
Returns for 3 years1.7810.9516%
Returns for 5 years29.2335.9581%
Returns for 10 years54.02N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology